ID   ACAD9_HUMAN             Reviewed;         621 AA.
AC   Q9H845; D3DNB8; Q8WXX3;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=Acyl-CoA dehydrogenase family member 9, mitochondrial;
DE            Short=ACAD-9;
DE            EC=1.3.99.-;
DE   Flags: Precursor;
GN   Name=ACAD9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Dendritic cell;
RX   PubMed=12359260; DOI=10.1016/S0006-291X(02)02336-7;
RA   Zhang J., Zhang W., Zou D., Chen G., Wan T., Zhang M., Cao X.;
RT   "Cloning and functional characterization of ACAD-9, a novel member of
RT   human acyl-CoA dehydrogenase family.";
RL   Biochem. Biophys. Res. Commun. 297:1033-1042(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN ACAD9 DEFICIENCY.
RX   PubMed=17564966; DOI=10.1086/519219;
RA   He M., Rutledge S.L., Kelly D.R., Palmer C.A., Murdoch G.,
RA   Majumder N., Nicholls R.D., Pei Z., Watkins P.A., Vockley J.;
RT   "A new genetic disorder in mitochondrial fatty acid beta-oxidation:
RT   ACAD9 deficiency.";
RL   Am. J. Hum. Genet. 81:87-103(2007).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-41, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH NDUFAF1 AND ECSIT,
RP   INVOLVEMENT IN ACAD9 DEFICIENCY, AND VARIANTS ACAD9 DEFICIENCY LYS-413
RP   AND HIS-518.
RX   PubMed=20816094; DOI=10.1016/j.cmet.2010.08.002;
RA   Nouws J., Nijtmans L., Houten S.M., van den Brand M., Huynen M.,
RA   Venselaar H., Hoefs S., Gloerich J., Kronick J., Hutchin T.,
RA   Willems P., Rodenburg R., Wanders R., van den Heuvel L., Smeitink J.,
RA   Vogel R.O.;
RT   "Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative
RT   phosphorylation complex I.";
RL   Cell Metab. 12:283-294(2010).
RN   [8]
RP   INVOLVEMENT IN ACAD9 DEFICIENCY, AND VARIANTS ACAD9 DEFICIENCY ILE-44;
RP   TRP-193; PHE-234; GLN-266; SER-303; THR-326; CYS-417 AND TRP-532.
RX   PubMed=21057504; DOI=10.1038/ng.706;
RA   Haack T.B., Danhauser K., Haberberger B., Hoser J., Strecker V.,
RA   Boehm D., Uziel G., Lamantea E., Invernizzi F., Poulton J.,
RA   Rolinski B., Iuso A., Biskup S., Schmidt T., Mewes H.W., Wittig I.,
RA   Meitinger T., Zeviani M., Prokisch H.;
RT   "Exome sequencing identifies ACAD9 mutations as a cause of complex I
RT   deficiency.";
RL   Nat. Genet. 42:1131-1134(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF GLU-426.
RX   PubMed=24158852; DOI=10.1093/hmg/ddt521;
RA   Nouws J., Te Brinke H., Nijtmans L.G., Houten S.M.;
RT   "ACAD9, a complex I assembly factor with a moonlighting function in
RT   fatty acid oxidation deficiencies.";
RL   Hum. Mol. Genet. 23:1311-1319(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   VARIANTS ACAD9 DEFICIENCY LYS-127; TRP-469 AND TRP-532.
RX   PubMed=20929961; DOI=10.1093/brain/awq273;
RA   Gerards M., van den Bosch B.J., Danhauser K., Serre V.,
RA   van Weeghel M., Wanders R.J., Nicolaes G.A., Sluiter W.,
RA   Schoonderwoerd K., Scholte H.R., Prokisch H., Rotig A., de Coo I.F.,
RA   Smeets H.J.;
RT   "Riboflavin-responsive oxidative phosphorylation complex I deficiency
RT   caused by defective ACAD9: new function for an old gene.";
RL   Brain 134:210-219(2011).
RN   [14]
RP   VARIANT ACAD9 DEFICIENCY TRP-532.
RX   PubMed=22499348; DOI=10.1136/jmedgenet-2012-100846;
RA   Haack T.B., Haberberger B., Frisch E.M., Wieland T., Iuso A.,
RA   Gorza M., Strecker V., Graf E., Mayr J.A., Herberg U.,
RA   Hennermann J.B., Klopstock T., Kuhn K.A., Ahting U., Sperl W.,
RA   Wilichowski E., Hoffmann G.F., Tesarova M., Hansikova H., Zeman J.,
RA   Plecko B., Zeviani M., Wittig I., Strom T.M., Schuelke M.,
RA   Freisinger P., Meitinger T., Prokisch H.;
RT   "Molecular diagnosis in mitochondrial complex I deficiency using exome
RT   sequencing.";
RL   J. Med. Genet. 49:277-283(2012).
RN   [15]
RP   VARIANT ACAD9 DEFICIENCY CYS-414.
RX   PubMed=23836383; DOI=10.1001/jamaneurol.2013.3197;
RA   Garone C., Donati M.A., Sacchini M., Garcia-Diaz B., Bruno C.,
RA   Calvo S., Mootha V.K., Dimauro S.;
RT   "Mitochondrial encephalomyopathy due to a novel mutation in ACAD9.";
RL   JAMA Neurol. 70:1177-1179(2013).
RN   [16]
RP   VARIANT ACAD9 DEFICIENCY VAL-220.
RX   PubMed=23996478; DOI=10.1007/8904_2013_242;
RA   Nouws J., Wibrand F., van den Brand M., Venselaar H., Duno M.,
RA   Lund A.M., Trautner S., Nijtmans L., Ostergard E.;
RT   "A patient with complex I deficiency caused by a novel ACAD9 mutation
RT   not responding to riboflavin treatment.";
RL   JIMD Rep. 12:37-45(2014).
RN   [17]
RP   VARIANTS ACAD9 DEFICIENCY GLY-271; MET-384 AND HIS-606.
RX   PubMed=26741492; DOI=10.1371/journal.pgen.1005679;
RA   Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y.,
RA   Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y., Kato H.,
RA   Okuda A., Tamaru S., Borna N.N., Banshoya K., Aigaki T.,
RA   Sato-Miyata Y., Ohnuma K., Suzuki T., Nagao A., Maehata H.,
RA   Matsuda F., Higasa K., Nagasaki M., Yasuda J., Yamamoto M.,
RA   Fushimi T., Shimura M., Kaiho-Ichimoto K., Harashima H., Yamazaki T.,
RA   Mori M., Murayama K., Ohtake A., Okazaki Y.;
RT   "A comprehensive genomic analysis reveals the genetic landscape of
RT   mitochondrial respiratory chain complex deficiencies.";
RL   PLoS Genet. 12:E1005679-E1005679(2016).
CC   -!- FUNCTION: Required for mitochondrial complex I assembly
CC       (PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity
CC       on palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0). It is three
CC       times more active on palmitoyl-CoA than on stearoyl-CoA. However,
CC       it does not play a primary role in long-chain fatty acid oxidation
CC       in vivo (PubMed:20816094, PubMed:24158852). Has little activity on
CC       octanoyl-CoA (C8:0), butyryl-CoA (C4:0) or isovaleryl-CoA (5:0).
CC       {ECO:0000269|PubMed:20816094, ECO:0000269|PubMed:24158852}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Part of the mitochondrial complex I assembly (MCIA)
CC       complex. The complex comprises at least TMEM126B, NDUFAF1, ECSIT,
CC       and ACAD9 (By similarity). Interacts with NDUFAF1 and ECSIT
CC       (PubMed:20816094). {ECO:0000250, ECO:0000269|PubMed:20816094}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:20816094}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in most normal human
CC       tissues and cancer cell lines with high level of expression in
CC       heart, skeletal muscles, brain, kidney and liver.
CC       {ECO:0000269|PubMed:12359260}.
CC   -!- DISEASE: Acyl-CoA dehydrogenase family, member 9, deficiency
CC       (ACAD9 deficiency) [MIM:611126]: An autosomal recessive metabolic
CC       disorder associated with mitochondrial complex I deficiency,
CC       resulting in multisystemic and variable manifestations. Clinical
CC       features include infantile onset of acute metabolic acidosis,
CC       Reye-like episodes (brain edema and vomiting that may rapidly
CC       progress to seizures, coma and death), exercise intolerance,
CC       hypertrophic cardiomyopathy, liver failure, muscle weakness, and
CC       neurologic dysfunction. {ECO:0000269|PubMed:17564966,
CC       ECO:0000269|PubMed:20816094, ECO:0000269|PubMed:20929961,
CC       ECO:0000269|PubMed:21057504, ECO:0000269|PubMed:22499348,
CC       ECO:0000269|PubMed:23836383, ECO:0000269|PubMed:23996478,
CC       ECO:0000269|PubMed:26741492}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF327351; AAL56011.1; -; mRNA.
DR   EMBL; AK024012; BAB14775.1; -; mRNA.
DR   EMBL; CH471052; EAW79295.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79296.1; -; Genomic_DNA.
DR   EMBL; BC013354; AAH13354.1; -; mRNA.
DR   EMBL; BC007970; AAH07970.1; -; mRNA.
DR   CCDS; CCDS3053.1; -.
DR   PIR; JC7892; JC7892.
DR   RefSeq; NP_054768.2; NM_014049.4.
DR   UniGene; Hs.567482; -.
DR   UniGene; Hs.734399; -.
DR   ProteinModelPortal; Q9H845; -.
DR   SMR; Q9H845; -.
DR   BioGrid; 118799; 69.
DR   DIP; DIP-53699N; -.
DR   IntAct; Q9H845; 37.
DR   STRING; 9606.ENSP00000312618; -.
DR   SwissLipids; SLP:000000619; -.
DR   iPTMnet; Q9H845; -.
DR   PhosphoSitePlus; Q9H845; -.
DR   SwissPalm; Q9H845; -.
DR   BioMuta; ACAD9; -.
DR   DMDM; 32469596; -.
DR   EPD; Q9H845; -.
DR   MaxQB; Q9H845; -.
DR   PaxDb; Q9H845; -.
DR   PeptideAtlas; Q9H845; -.
DR   PRIDE; Q9H845; -.
DR   DNASU; 28976; -.
DR   Ensembl; ENST00000308982; ENSP00000312618; ENSG00000177646.
DR   GeneID; 28976; -.
DR   KEGG; hsa:28976; -.
DR   UCSC; uc003ela.5; human.
DR   CTD; 28976; -.
DR   DisGeNET; 28976; -.
DR   GeneCards; ACAD9; -.
DR   H-InvDB; HIX0003659; -.
DR   HGNC; HGNC:21497; ACAD9.
DR   HPA; HPA037716; -.
DR   HPA; HPA046720; -.
DR   MalaCards; ACAD9; -.
DR   MIM; 611103; gene.
DR   MIM; 611126; phenotype.
DR   neXtProt; NX_Q9H845; -.
DR   OpenTargets; ENSG00000177646; -.
DR   Orphanet; 99901; Acyl-CoA dehydrogenase 9 deficiency.
DR   Orphanet; 2609; Isolated NADH-CoQ reductase deficiency.
DR   PharmGKB; PA134900655; -.
DR   eggNOG; KOG0137; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131665; -.
DR   HOVERGEN; HBG050448; -.
DR   InParanoid; Q9H845; -.
DR   KO; K15980; -.
DR   OMA; MKEEIFM; -.
DR   OrthoDB; EOG091G04BS; -.
DR   PhylomeDB; Q9H845; -.
DR   TreeFam; TF105053; -.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   SABIO-RK; Q9H845; -.
DR   GeneWiki; ACAD9; -.
DR   GenomeRNAi; 28976; -.
DR   PRO; PR:Q9H845; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000177646; -.
DR   CleanEx; HS_ACAD9; -.
DR   ExpressionAtlas; Q9H845; baseline and differential.
DR   Genevisible; Q9H845; HS.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 2.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Disease mutation; FAD; Flavoprotein;
KW   Mitochondrion; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    621       Acyl-CoA dehydrogenase family member 9,
FT                                mitochondrial.
FT                                /FTId=PRO_0000000524.
FT   ACT_SITE    426    426       Proton acceptor. {ECO:0000250}.
FT   MOD_RES      41     41       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      92     92       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8JZN5}.
FT   MOD_RES     478    478       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8JZN5}.
FT   MOD_RES     521    521       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8JZN5}.
FT   MOD_RES     521    521       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8JZN5}.
FT   VARIANT      44     44       F -> I (in ACAD9 deficiency;
FT                                dbSNP:rs387907041).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071892.
FT   VARIANT     127    127       R -> K (in ACAD9 deficiency).
FT                                {ECO:0000269|PubMed:20929961}.
FT                                /FTId=VAR_071893.
FT   VARIANT     193    193       R -> W (in ACAD9 deficiency; unknown
FT                                pathological significance;
FT                                dbSNP:rs377547811).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071894.
FT   VARIANT     220    220       A -> V (in ACAD9 deficiency).
FT                                {ECO:0000269|PubMed:23996478}.
FT                                /FTId=VAR_071895.
FT   VARIANT     234    234       S -> F (in ACAD9 deficiency; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071896.
FT   VARIANT     266    266       R -> Q (in ACAD9 deficiency;
FT                                dbSNP:rs387907042).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071897.
FT   VARIANT     271    271       C -> G (in ACAD9 deficiency).
FT                                {ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076177.
FT   VARIANT     303    303       G -> S (in ACAD9 deficiency; unknown
FT                                pathological significance;
FT                                dbSNP:rs143383023).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071898.
FT   VARIANT     326    326       A -> T (in ACAD9 deficiency; unknown
FT                                pathological significance;
FT                                dbSNP:rs115532916).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071899.
FT   VARIANT     384    384       V -> M (in ACAD9 deficiency).
FT                                {ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076178.
FT   VARIANT     413    413       E -> K (in ACAD9 deficiency; unknown
FT                                pathological significance;
FT                                dbSNP:rs149753643).
FT                                {ECO:0000269|PubMed:20816094}.
FT                                /FTId=VAR_071900.
FT   VARIANT     414    414       R -> C (in ACAD9 deficiency;
FT                                dbSNP:rs777282696).
FT                                {ECO:0000269|PubMed:23836383}.
FT                                /FTId=VAR_071901.
FT   VARIANT     417    417       R -> C (in ACAD9 deficiency;
FT                                dbSNP:rs368949613).
FT                                {ECO:0000269|PubMed:21057504}.
FT                                /FTId=VAR_071902.
FT   VARIANT     469    469       R -> W (in ACAD9 deficiency;
FT                                dbSNP:rs139145143).
FT                                {ECO:0000269|PubMed:20929961}.
FT                                /FTId=VAR_071903.
FT   VARIANT     477    477       R -> Q (in dbSNP:rs4494951).
FT                                /FTId=VAR_033459.
FT   VARIANT     518    518       R -> H (in ACAD9 deficiency;
FT                                dbSNP:rs781149699).
FT                                {ECO:0000269|PubMed:20816094}.
FT                                /FTId=VAR_071904.
FT   VARIANT     532    532       R -> W (in ACAD9 deficiency;
FT                                dbSNP:rs377022708).
FT                                {ECO:0000269|PubMed:20929961,
FT                                ECO:0000269|PubMed:21057504,
FT                                ECO:0000269|PubMed:22499348}.
FT                                /FTId=VAR_071905.
FT   VARIANT     606    606       L -> H (in ACAD9 deficiency).
FT                                {ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076179.
FT   MUTAGEN     426    426       E->Q: Catalytically inactive. Does not
FT                                affect mitochondrial complex I assembly.
FT                                {ECO:0000269|PubMed:24158852}.
FT   CONFLICT    397    397       A -> V (in Ref. 1; AAL56011).
FT                                {ECO:0000305}.
SQ   SEQUENCE   621 AA;  68760 MW;  064BCE0378877F54 CRC64;
     MSGCGLFLRT TAAARACRGL VVSTANRRLL RTSPPVRAFA KELFLGKIKK KEVFPFPEVS
     QDELNEINQF LGPVEKFFTE EVDSRKIDQE GKIPDETLEK LKSLGLFGLQ VPEEYGGLGF
     SNTMYSRLGE IISMDGSITV TLAAHQAIGL KGIILAGTEE QKAKYLPKLA SGEHIAAFCL
     TEPASGSDAA SIRSRATLSE DKKHYILNGS KVWITNGGLA NIFTVFAKTE VVDSDGSVKD
     KITAFIVERD FGGVTNGKPE DKLGIRGSNT CEVHFENTKI PVENILGEVG DGFKVAMNIL
     NSGRFSMGSV VAGLLKRLIE MTAEYACTRK QFNKRLSEFG LIQEKFALMA QKAYVMESMT
     YLTAGMLDQP GFPDCSIEAA MVKVFSSEAA WQCVSEALQI LGGLGYTRDY PYERILRDTR
     ILLIFEGTNE ILRMYIALTG LQHAGRILTT RIHELKQAKV STVMDTVGRR LRDSLGRTVD
     LGLTGNHGVV HPSLADSANK FEENTYCFGR TVETLLLRFG KTIMEEQLVL KRVANILINL
     YGMTAVLSRA SRSIRIGLRN HDHEVLLANT FCVEAYLQNL FSLSQLDKYA PENLDEQIKK
     VSQQILEKRA YICAHPLDRT C
//
